Business

Innovotech awarded $300,000 in grant funding to develop InnovoSIL-1 Antimicrobial Silver

(TheNewswire) Edmonton, Alberta - TheNewswire - 28 November, 2023 - Inn...

articleInnovotech Inc.November 28, 20233/company/innovotech-inc/news/innovotech-awarded-dollar300000-in-grant-funding-to-develop-innovosil-1-antimicrobial-silver
Innovotech awarded $300,000 in grant funding to develop InnovoSIL-1 Antimicrobial Silver

About this update from Innovotech Inc.

[{"type":"text","content":"Innovotech awarded $300,000 in grant funding to develop InnovoSIL-1 Antimicrobial Silver \n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Edmonton, Alberta\n \n \n -\n \n \n TheNewswire -\n \n \n 28 November,\n2023 -\n \n \n \n \n Innovotech Inc.\n \n \n \n \n (TSX-V:IOT)\n \n \n has been\nawarded $300,000 in grant funding through Alberta Innovates to develop\nInnovoSIL™-1, the first in a\n \n \n family of\nrevolutionary new antimicrobial silver compounds developed and\npatented by Innovotech. InnovoSIL™-1 silver has uniquely effective\nproperties for eliminating preformed biofilms and preventing microbial\nadherence to surfaces. It has long lasting efficacy against a broad\nspectrum of microbes and does not suffer from rapid inactivation in\nbodily fluids, unlike many commercially available silver\ncompounds.\n \n \n \n \n The\n \n \n non-refundable contributions\nwere awarded by Alberta Innovates under the “Accelerating\nInnovations into CarE” program, also knowns as AICE.  Alberta\nInnovates will contribute $300,000 with Innovotech supporting a\nminimum of $100,000 from cash and in-kind resources.\n \n \n \n \n Innovotech plans to use the funding for antiviral\ntesting, scale-up of manufacturing methods, and further coating\nprocess development.\n \n \n \n \n “We are excited for the opportunity provided to us\nthrough this grant.  It will allow us to further develop knowledge\nof, and applications for, InnovoSIL™-1 silver, so that we can better\nsupport collaborators interested in including it as an antimicrobial\nin their product line,” says Dr. Patricia Nadworny, Chief Scientific\nOfficer at Innovotech.\n \n \n \n \n Innovotech is working with collaborators to\ncommercialize InnovoSIL™-1 silver across different applications and\nis actively seeking additional opportunities for development or\nlicensing.\n \n \n \n \n About Innovotech Inc:\n \n \n \n \n Innovotech is a Canadian biotechnology company owning\nproprietary intellectual property, conducting contract research, and\nowning and providing proprietary devices for testing in multiple\napplications in microbiology and can be found online at\n \n \n www.innovotech.ca\n \n \n .\n \n \n \n \n Craig Milne, CEO,\n \n \n Innovotech Inc.\n \n \n \n \n +1-604 220-4935, craig...

More updates from Innovotech Inc.